Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.635 USD | -3.41% | -2.16% | -14.83% |
May. 07 | Traws Pharma Completes First Cohort Dosed in Phase 1 Trial for COVID Therapy | CI |
Apr. 04 | North American Morning Briefing : Focus Turns to -2- | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.83% | 13.86M | |
+29.13% | 49.46B | |
+0.54% | 42.58B | |
+48.88% | 42.49B | |
-5.26% | 29.09B | |
+12.18% | 26.61B | |
-24.27% | 18.64B | |
+7.24% | 13.16B | |
+31.96% | 12.55B | |
+24.17% | 12.1B |
- Stock Market
- Equities
- TRAW Stock
- News Traws Pharma, Inc.
- Onconova Therapeutics, Pangea Biomed Collaborate to Identify Biomarkers of Response to Rigosertib